Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1984 Sep;26(3):354–357. doi: 10.1128/aac.26.3.354

Treatment of primary acute genital herpes in guinea pigs by intraperitoneal administration of fluoropyrimidines.

D R Mayo, G D Hsiung
PMCID: PMC176169  PMID: 6239591

Abstract

FIAC [1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine], FIAU [1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil], and FMAU [1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-methyluracil] were evaluated for their efficacies in the treatment of genital infections with herpes simplex virus type 2 in guinea pigs. Intraperitoneal administration of these drugs in daily doses of 100 mg/kg of body weight initiated 24 h after virus inoculation and repeated 2 successive days thereafter inhibited development of genital lesions and reduced shedding of virus without evoking untoward reactions. In a comparative study with this 3-day dosage schedule, the efficacy of daily doses of 50 mg of FMAU per kg was greater than that of the same doses of FIAC and FIAU, in that order; all these were more effective than daily doses of 50, 100, or 200 mg of acyclovir or of 500 mg of phosphonoformic acid per kg. These differences in efficacy were enhanced when treatment was delayed for 2 to 3 days after inoculation.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alenius S., Nordlinder H. Effect of trisodium phosphonoformate in genital infection of female guinea pigs with herpes simplex virus type 2. Arch Virol. 1979;60(3-4):197–206. doi: 10.1007/BF01317491. [DOI] [PubMed] [Google Scholar]
  2. De Clercq E., Descamps J., Verhelst G., Walker R. T., Jones A. S., Torrence P. F., Shugar D. Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus. J Infect Dis. 1980 May;141(5):563–574. doi: 10.1093/infdis/141.5.563. [DOI] [PubMed] [Google Scholar]
  3. Kern E. R. Acyclovir treatment of experimental genital herpes simplex virus infections. Am J Med. 1982 Jul 20;73(1A):100–108. doi: 10.1016/0002-9343(82)90073-0. [DOI] [PubMed] [Google Scholar]
  4. Kern E. R., Glasgow L. A., Klein R. J., Friedman-Kien A. E. Failure of 2-deoxy-D-glucose in the treatment of experimental cutaneous and genital infections due to herpes simplex virus. J Infect Dis. 1982 Aug;146(2):159–166. doi: 10.1093/infdis/146.2.159. [DOI] [PubMed] [Google Scholar]
  5. Landry M. L., Lucia H. L., Hsiung G. D., Pronovost A. D., Dann P. R., August M. J., Mayo D. R. Effect of acyclovir on genital infection with herpes simplex virus types 1 and 2 in the guinea pig. Am J Med. 1982 Jul 20;73(1A):143–150. doi: 10.1016/0002-9343(82)90080-8. [DOI] [PubMed] [Google Scholar]
  6. Lucia H. L., Griffith B. P., Hsiung G. D. Effect of acyclovir and phosphonoformate on cytomegalovirus infection in guinea pigs. Intervirology. 1984;21(3):141–149. doi: 10.1159/000149512. [DOI] [PubMed] [Google Scholar]
  7. Lukás B., Wiesendanger W., Schmidt-Ruppin K. H. Genital herpes in guinea-pigs. An experimental model with Herpesvirus hominis. Arch Gesamte Virusforsch. 1974;44(2):153–155. doi: 10.1007/BF01250226. [DOI] [PubMed] [Google Scholar]
  8. Mayo D. R. Differentiation of herpes simplex virus types 1 and 2 by sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine. J Clin Microbiol. 1982 Apr;15(4):733–736. doi: 10.1128/jcm.15.4.733-736.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mayo D. R., Lucia H. L., Hsiung G. D. Effect of phosphonoformate on symptomatic genital herpes simplex virus type 2 infection of guinea pigs. Intervirology. 1983;19(1):26–32. doi: 10.1159/000149333. [DOI] [PubMed] [Google Scholar]
  10. Nordlund J. J., Anderson C., Hsiung G. D., Tenser R. B. The use of temperature sensitivity and selective cell culture systems for differentiation of herpes simplex virus types 1 and 2 in a clinical laboratory. Proc Soc Exp Biol Med. 1977 May;155(1):118–123. doi: 10.3181/00379727-155-39757. [DOI] [PubMed] [Google Scholar]
  11. Richards J. T., Kern E. R., Overall J. C., Jr, Glasgow L. A. Anti-herpesvirus activity of adenine arabinoside analogues in tissue culture and a genital infection of mice and guinea pigs. Antiviral Res. 1982 May;2(1-2):27–39. doi: 10.1016/0166-3542(82)90024-9. [DOI] [PubMed] [Google Scholar]
  12. Schinazi R. F., Peters J., Sokol M. K., Nahmias A. J. Therapeutic activities of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine and -thymine alone and in combination with acyclovir and vidarabine in mice infected intracerebrally with herpes simplex virus. Antimicrob Agents Chemother. 1983 Jul;24(1):95–103. doi: 10.1128/aac.24.1.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Scriba M. Herpes simplex virus infection in guinea pigs: an animal model for studying latent and recurrent herpes simplex virus infection. Infect Immun. 1975 Jul;12(1):162–165. doi: 10.1128/iai.12.1.162-165.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Shannon W. M., Arnett G., Drennen D. J. Lack of efficacy of 2-deoxy-D-glucose in the treatment of experimental herpes genitalis in guinea pigs. Antimicrob Agents Chemother. 1982 Mar;21(3):513–515. doi: 10.1128/aac.21.3.513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Stanberry L. R., Kern E. R., Richards J. T., Abbott T. M., Overall J. C., Jr Genital herpes in guinea pigs: pathogenesis of the primary infection and description of recurrent disease. J Infect Dis. 1982 Sep;146(3):397–404. doi: 10.1093/infdis/146.3.397. [DOI] [PubMed] [Google Scholar]
  16. Trousdale M. D., Nesburn A. B., Su T. L., Lopez C., Watanabe K. A., Fox J. J. Activity of 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)thymine against herpes simplex virus in cell cultures and rabbit eyes. Antimicrob Agents Chemother. 1983 Jun;23(6):808–813. doi: 10.1128/aac.23.6.808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Trousdale M. D., Nesburn A. B., Watanabe K. A., Fox J. J. Evaluation of the antiherpetic activity of 2'-fluoro-5-iodo-ara-C in rabbit eyes and cell cultures. Invest Ophthalmol Vis Sci. 1981 Dec;21(6):826–832. [PubMed] [Google Scholar]
  18. Watanabe K. A., Reichman U., Hirota K., Lopez C., Fox J. J. Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides. J Med Chem. 1979 Jan;22(1):21–24. doi: 10.1021/jm00187a005. [DOI] [PubMed] [Google Scholar]
  19. Zheng Z. M., Mayo D. R., Hsiung G. D. Effect of CP-20,961 on genital herpes in guinea pigs. Antiviral Res. 1983 Nov;3(4):275–283. doi: 10.1016/0166-3542(83)90006-2. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES